New insights into antibody levels against SARS-CoV-2 for healthcare personnel vaccinated with tozinameran (Comirnaty)Article Published on 2022-11-032022-11-15 Journal: PLoS ONE [Category] SARS, 진단, [키워드] activated addition addressed administration Alto Andújar antibody booster dose COVID-19 determine Dilution Elecsy Evolution exhibited Germany Guadalquivir healthcare personnel Healthcare professional humoral IgG in vitro infected patients material Neutralizing antibodies New non-infected pandemic platform Roche SARS-CoV-2 SARS-CoV-2 vaccine second dose serum sample Spike protein subject Thermo Fisher Scientific titer total antibody vaccination Vaccine Volunteer volunteers [DOI] 10.1371/journal.pone.0276968 PMC 바로가기
Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) StudyArticle Published on 2022-10-262022-11-15 Journal: mBio [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI 95% confidence interval acute respiratory syndrome addition adopted Adverse adverse event AEs amplification antibodies CCP Clinical outcome competing Concentration conducted convalescent convalescent plasma coronavirus COVID-19 death defined donors dose response Effectiveness eligible evaluate evaluated event Fisher Gray hazard ratio heterogeneity high-risk population hospital hospital discharge immunology Inconclusive Infection Lower Mortality NAb Neutralizing antibodies neutralizing antibodies. neutralizing antibody observational study occurred participant Patient positive primary clinical outcome randomized control trial receiving Registered Research Respiratory Support Result risk SAEs SARS-CoV-2 SARS-CoV-2 nucleic acid screened Secondary outcomes severe COVID-19 Standard of care Support Symptom therapeutic therapy time titer Treatment [DOI] 10.1128/mbio.01751-22 PMC 바로가기
Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated IndividualsArticle Published on 2022-10-262022-11-15 Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 진단, [키워드] ACE-2 ACE2 ACE2 binding analyzed Angiotensin converting enzyme-2 Anti-RBD IgG Anti-spike anti-spike antibody anti-Spike IgG antibody binding blood collection BNT162b2 calculated collected Concentration correlated correlation correlation coefficient correlation coefficients COVID-19 COVID-19 antibody demonstrated dosing interval examined Fisher group groups IgG individual inhibition interval intervals labor-intensive measure mRNA mRNA-1273 vaccines Neutralizing antibodies neutralizing antibodies. neutralizing antibody Neutralizing antibody titer neutralizing antibody titers NTD Participants performed RBD Sample SARS-CoV-2 Secondary analyses Spearman correlation coefficient subgroup tested the median the vaccine titer vaccinated individual vaccination Vaccine vaccinee vaccinees Validity viral neutralization wild-type with COVID-19 women [DOI] 10.1128/spectrum.01315-22 PMC 바로가기
Comparative Analysis of Antibody Titers against the Spike Protein of SARS-CoV-2 Variants in Infected Patient Cohorts and Diverse Vaccination RegimesArticle Published on 2022-10-132022-11-15 Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] accompanied antibody Antibody Response AstraZeneca B cell benefit booster vaccination cells Comparative courses COVID-19 COVID-19 pandemic Critical critical COVID-19 patients exceeded follicular Frequency Infection Inflammation Inflammatory response Johnson & Johnson long-COVID Lymphocytes Mild Moderna mRNA vaccine neutralizing antibody patients patients who survived Pfizer-BioNTech recommendation reduced regime SARS-CoV-2 SARS-CoV-2 patient severe COVID-19 disease the SARS-CoV-2 virus the Spike titer understanding vaccination Vaccination strategy vaccination. Vaccine [DOI] 10.3390/ijms232012231 PMC 바로가기
The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral ImmunityArticle Published on 2022-09-262022-11-15 Journal: International Journal of Molecular Sciences [Category] SARS, 변종, 진단, [키워드] ACE2 ACE2 binding amino acid changes antibody bamlanivimab Better bind binding BNT162b2 BNT162b2 mRNA BNT162b2 vaccine chance COVID-19 Delta delta variant dropped evaluate the effect human Angiotensin-converting enzyme immunized individual L452R Lambda less Ligand mRNA Mutation mutations Protective protective effect RBD Receptor binding domain SARS-CoV-2 sera serum antibody serum antibody. T478K the RBD titer vaccinated individual vaccination Vaccine variant variants of concern variants of interest VoC WHO wild type World Health Organization [DOI] 10.3390/ijms231911325 PMC 바로가기
Serum Proteome Signatures of Anti-SARS-CoV-2 Vaccinated Healthcare Workers in Greece Associated with Their Prior Infection StatusArticle Published on 2022-09-052022-11-15 Journal: International Journal of Molecular Sciences [Category] SARS, 유전자 메커니즘, 진단, [키워드] affected All participant analyzed anti-SARS-CoV-2 anti-SARS-CoV-2 vaccination approach bioinformatics blood sample BNT162b2 mRNA Characteristics collected contribute contributed controls Course COVID-19 COVID-19 vaccination COVID-19 vaccine database differentially expressed down-regulated Gene ontology Greece humoral immune response identify IgG immune response Immune status individuals infected patient KEGG knowledge Kyoto LC-MS/MS majority mechanism molecular over pandemic pathogenic pathway Pfizer/BioNTech processed profiling analysis Protein proteome proteomics provided Quantitative RBD-specific IgG recipients Research SARS-CoV-2 SARS-COV-2 infection sera serum signature significantly status the SARS-CoV-2 Thessaloniki titer vaccinated individual vaccination vaccination. Vaccine virus worker [DOI] 10.3390/ijms231710153 PMC 바로가기
Evaluation of long-term antibody kinetics in healthcare workers vaccinated with inactivated COVID-19 Vero cell vaccine (CoronaVac), a propensity score-matched observational studyObservational Study Published on 2022-09-012022-10-04 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 임상, 진단, [키워드] age antibody kinetics approval binding antibody booster CLIA CoronaVac Course COVID-19 COVID-19 vaccines ELISA enzyme-linked immunosorbent evaluate Factors HCW HCWs healthcare worker immunoassay inactivated NAb negative correlation neutralizing antibody optic density Participants Pearson correlation propensity score analysis prospective observational study response SARS-CoV-2 SARS-CoV-2 antibody significant decrease significantly single center the antibody response the vaccine titer Turkey Vaccine Vero Cell was determined was performed were used [DOI] 10.1016/j.ijid.2022.05.007 PMC 바로가기 [Article Type] Observational Study
Immune response in ofatumumab treated multiple sclerosis patients after SARS-CoV-2 vaccinationArticle Published on 2022-08-312022-11-15 Journal: Frontiers in Immunology [Category] SARS, 변종, 진단, [키워드] alteration anti-CD20 anti-CD20 therapy antibody applied approach B cell caused CD4 Cellular immune response cellular immunity characterized Complete decrease Delta disorder dosage Effect elicit Frequency healthy controls humoral humoral immune response immune Immune cell immune cells immune response Immunosuppression implication information investigated mean treatment duration Multiple multiple sclerosis neutralization capacity Ofatumumab ofatumumab. omicron pandemic Patient preserved Regulatory T cell SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 variant sclerosis subcutaneously subpopulation sustained T cell T cell response T helper Th1 titer treated treated patient Treatment Tregs vaccination was impaired wild type [DOI] 10.3389/fimmu.2022.980526 PMC 바로가기
Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough InfectionsArticle Published on 2022-08-302022-11-15 Journal: mBio [Category] SARS, 변종, 진단, [키워드] analyzed antibody Antibody neutralization Breakthrough infection breakthrough infections caused COVID-19 Delta delta variant determine exhibited humans immune evasion implication laboratory result less neutralization neutralization titer Neutralizing neutralizing antibody Neutralizing antibody titer Patient positive Prevent public health required SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant sera tested threshold titer to define Transmission USA-WA1/2020 vaccinated individual Vaccine vaccine booster variants of concern variants of concern. [DOI] 10.1128/mbio.01996-22 PMC 바로가기
SARS-CoV-2 Infectivity and Antibody Titer Reduction for 6 Months After Second Dose of BNT162b2 mRNA Vaccine in Health Care Workers: A Prospective Cohort Study의료 종사자에서 BNT162b2 mRNA 백신 2차 접종 후 6개월 동안 SARS-CoV-2 감염성 및 항체 역가 감소: 전향적 코호트 연구Article Published on 2022-08-122022-09-12 Journal: The Journal of Infectious Diseases [Category] SARS, 진단, [키워드] acute respiratory syndrome antibody antibody formation Antibody titer antibody titer dynamics binding domain blood sample Breakthrough infection breakthrough infections Care coronavirus disease Coronavirus-2 decrease dose enrolled HCW HCWs Health Health care worker health care workers individuals Infection Infectivity Month mRNA mRNA vaccination mRNA vaccination. neutralizing antibody no significant difference of BNT162b2 participant Probability Prospective receiving reduction reported SARS-CoV-2 second second vaccination titer vaccination [DOI] 10.1093/infdis/jiac035 PMC 바로가기 [Article Type] Article